For: | Moon HH, Seo KW, Yoon KY, Shin YM, Choi KH, Lee SH. Prediction of nephrotoxicity induced by cisplatin combination chemotherapy in gastric cancer patients. World J Gastroenterol 2011; 17(30): 3510-3517 [PMID: 21941418 DOI: 10.3748/wjg.v17.i30.3510] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i30/3510.htm |
Number | Citing Articles |
1 |
Zulfan Zazuli, Susanne Vijverberg, Elise Slob, Geoffrey Liu, Bruce Carleton, Joris Veltman, Paul Baas, Rosalinde Masereeuw, Anke-Hilse Maitland-van der Zee. Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01111
|
2 |
BEN SPRANGERS, LAURA COSMAI, CAMILLO PORTA. Onco-Nephrology. 2020; : 127 doi: 10.1016/B978-0-323-54945-5.00025-4
|
3 |
Ko Sato, Satoshi Watanabe, Aya Ohtsubo, Satoshi Shoji, Daisuke Ishikawa, Tomohiro Tanaka, Koichiro Nozaki, Rie Kondo, Masaaki Okajima, Satoru Miura, Junta Tanaka, Takuro Sakagami, Toshiyuki Koya, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita. Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2271-8
|
4 |
Somayeh Sadat Shariatmaghani, Alireza Saadat, Isa Nazar, Farnoush Davoudi, Shahram Parvin, Hossein Mehrani, Behzad Einollahi. Urinary Neutrophil Gelatinase Associated Lipocalin (NGAL) in Predicting Cisplatin-Induced Acute Kidney Injury. Nephro-Urology Monthly 2019; (In Press) doi: 10.5812/numonthly.87523
|
5 |
Noorwati Sutandyo, Puteri Wahyuni, Sri Agustini Kurniawati, Hilman Tadjoedin, Devina Adella. Cisplatin-induced Nephrotoxicty and its Predisposing Factors for Unrecovered Kidney Injury: A Report from Indonesia National Cancer Center. Open Access Macedonian Journal of Medical Sciences 2023; 11(B): 223 doi: 10.3889/oamjms.2023.11128
|
6 |
Chou-Chin Lan, Po-Chun Hsieh, Chun-Yao Huang, Mei-Chen Yang, Wen-Lin Su, Chih-Wei Wu, Yao-Kuang Wu. Review of epidermal growth factor receptor-tyrosine kinase inhibitors administration to non-small-cell lung cancer patients undergoing hemodialysis. World Journal of Clinical Cases 2022; 10(19): 6360-6369 doi: 10.12998/wjcc.v10.i19.6360
|
7 |
Ekanita Desiani, Suharjono Suharjono, Yulistiani Yulistiani, Dwi Hari Susilo. ANALYSIS OF NACL-MANNITOL HYDRATION ON RENAL FUNCTION OF HEAD AND NECK CANCER PATIENTS RECEIVING HIGH-DOSE CISPLATIN CHEMOTHERAPY COMBINATION. Folia Medica Indonesiana 2017; 53(1): 64 doi: 10.20473/fmi.v53i1.5492
|
8 |
Manal El Hamamsy, Noha Kamal, Naglaa Samir Bazan, Mostafa El Haddad. Evaluation of the effect of acetazolamide versus mannitol on cisplatin-induced nephrotoxicity, a pilot study. International Journal of Clinical Pharmacy 2018; 40(6): 1539 doi: 10.1007/s11096-018-0677-x
|
9 |
Foroud Shahbazi, Sanambar Sadighi, Simin Dashti‐Khavidaki, Farhad Shahi, Mehrzad Mirzania, Alireza Abdollahi, Mohammad‐Hossein Ghahremani. Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial. Phytotherapy Research 2015; 29(7): 1046 doi: 10.1002/ptr.5345
|
10 |
Shigeo Horie, Mototsugu Oya, Masaomi Nangaku, Yoshinari Yasuda, Yasuhiro Komatsu, Motoko Yanagita, Yuko Kitagawa, Hiroyuki Kuwano, Hiroyuki Nishiyama, Chikashi Ishioka, Hiromasa Takaishi, Hideki Shimodaira, Akira Mogi, Yuichi Ando, Koji Matsumoto, Daisuke Kadowaki, Satoru Muto. Guidelines for treatment of renal injury during cancer chemotherapy 2016. Clinical and Experimental Nephrology 2018; 22(1): 210 doi: 10.1007/s10157-017-1448-z
|
11 |
Takamitsu Inoue, Jun Miyazaki, Daishi Ichioka, Shintaro Narita, Susumu Kageyama, Mikio Sugimoto, Koji Mitsuzuka, Yusuke Shiraishi, Hidefumi Kinoshita, Hironobu Wakeda, Takeshi Nomoto, Eiji Kikuchi, Yoshiyuki Matsui, Keiko Fujie, Tomonori Habuchi, Hiroyuki Nishiyama. A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: a Japanese retrospective multi-institutional study. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4186-z
|
12 |
Wiem Ben Ayed, Azza Ben Said, Adel Hamdi, Amina Mokrani, Yosri Masmoudi, Imen Toukabri, Imen Limayem, Yosra Yahyaoui. Toxicity, risk factors and management of cisplatin-induced toxicity: A prospective study. Journal of Oncology Pharmacy Practice 2020; 26(7): 1621 doi: 10.1177/1078155219901305
|
13 |
Kazumi Komaki, Tetsuro Kusaba, Mai Tanaka, Hiroshi Kado, Yayoi Shiotsu, Masahiro Matsui, Atsushi Shiozaki, Hiroshi Nakano, Takeshi Ishikawa, Hitoshi Fujiwara, Hideyuki Konishi, Yoshito Itoh, Satoaki Matoba, Keiichi Tamagaki. Lower blood pressure and risk of cisplatin nephrotoxicity: a retrospective cohort study. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3135-6
|
14 |
Yenny Prasaja, Noorwati Sutandyo, Retnosari Andrajati. Incidence of Cisplatin-Induced Nephrotoxicity and Associated Factors among Cancer Patients in Indonesia. Asian Pacific Journal of Cancer Prevention 2015; 16(3): 1117 doi: 10.7314/APJCP.2015.16.3.1117
|
15 |
Andhika Rachman, Hamzah Shatri, Ruben Salamat. Correlation Between Higher Cumulative Dose of Cisplatin for Concurrent Chemoradiation and Acute Kidney Disease Incidence Among Nasopharyngeal Carcinoma Patients: A Comparative Study. International Journal of General Medicine 2021; : 10527 doi: 10.2147/IJGM.S343644
|
16 |
Zulfan Zazuli, Renate Kos, Joris D. Veltman, Wilma Uyterlinde, Cristina Longo, Paul Baas, Rosalinde Masereeuw, Susanne J. H. Vijverberg, Anke-Hilse Maitland-van der Zee. Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00975
|
17 |
Wala Ben Kridis, Mayssa Lajnef, Afef Khanfir. Acute renal failure during cisplatin-based chemotherapy: A prospective monocentric study. Journal of Oncology Pharmacy Practice 2024; 30(6): 1023 doi: 10.1177/10781552231199984
|